Fludarabine-based stem cell transplantation protocol for Fanconi's anaemia in myelodysplastic transformation

21Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Allogeneic stem cell transplantation (SCT) represents the treatment of choice for severe bone marrow (BM) failure in patients with Fanconi's anaemia (FA). However, for FA patients developing leukaemic or myelodysplastic transformation, the results of SCT are much less encouraging. We present a 1 7-year-old girl with myelodysplastic transformation of FA (refractory anaemia with excess blasts) and oculocutaneous albinism, who was treated by sibling SCT using conditioning with fludarabine, cyclophosphamide (CY) and anti-lymphocyte globulin (ALG). She had rapid engraftment with no toxicity and no graft-versus-host disease (GVHD). Twenty-two months after SCT, she had 100% donor chimaerism on Southern blot analysis.

Cite

CITATION STYLE

APA

McCloy, M., Almeida, A., Daly, P., Vulliamy, T., Roberts, I. A. G., & Dokal, I. (2001). Fludarabine-based stem cell transplantation protocol for Fanconi’s anaemia in myelodysplastic transformation. British Journal of Haematology, 112(2), 427–429. https://doi.org/10.1046/j.1365-2141.2001.02585.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free